News and Trends 23 Aug 2017
Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs
Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2 diabetes and obesity discovered through a partnership with Danish biotech Zealand. The new Phase I…